Search clinical trials for: sirolimus-eluting balloon (SEB) MagicTouch

Total 398 results

Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD)

Coronary Artery Disease

China
University Health Network, Toronto

Unknown

Paclitaxel Eluting Balloon for SFA In-stent Restenosis

In-stent Arterial Restenosis

Canada
University of Patras

Completed

Infrapopliteal Drug Eluting Angioplasty Versus Stenting (IDEAS-I)

Arterial Occlusive Disease

Greece
Shanghai Bio-heart Biological Technology Co., Ltd.

Unknown

Galaxy Rapamycin Drug-Eluting Bioresorbable Coronary Stent System First-in-man Study

Heart Diseases
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Evaluation of New Specifications (38mm) of FirehawkTM in the Treatment of Coronary Heart Disease (Firehawk_38)

Coronary Heart Disease

China
Centre hospitalier de l'Université de Montréal...
Biotronik Canada Inc

Completed

Drug Eluting Balloon for Prevention of Hemodialysis Access Restenosis (DEB)

Arteriovenous Graft | Arteriovenous Fistulae

Canada
Ospedale San Donato

Unknown

Evaluating the Effectiveness of Paclitaxel-eluting Balloons for Below-the-knee Angioplasty in Patients With Critical Limb Ischemia

Critical Limb Ischemia

Italy
University Health Network, Toronto

Completed

Restenosis Following Paclitaxel Eluting Balloon Angioplasty of Hemodialysis Access Stenosis

Renal Failure

Canada
Medtronic Vascular

Completed

RESOLUTE ONYX Post-Approval Study (ONYX PAS)

Coronary Artery Disease

United States, Belgium, France, Slovakia
National Taiwan University Hospital

Unknown

Imaging and Interventional Study for Erectile Dysfunction and Lower Urinary Tract Symptoms (PERFECT)

Lower Urinary Tract Symptoms | Peripheral Arterial Disease | Erectile Dysfunction

Taiwan
Shanghai Bomaian Medical Technology Co., Ltd

Not yet recruiting

Rapamycin Coated Balloon Dilation Catheter for Arteriovenous Fistula

Peripheral Arterial Disease
Shanghai Bio-heart Biological Technology Co., Ltd.
CCRF Inc., Beijing, China

Not yet recruiting

A Registry Trial of The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System

Coronary Artery Disease

China
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb

Active, not recruiting

A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer

Liver Cancer

United States
Translumina GmbH

Terminated

Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis

Coronary Disease

Germany, Israel, Austria
Klinikum Coburg

Unknown

Treatment of Drug-eluting Stent (DES) In-Stent Restenosis With SeQuent® Please Paclitaxel Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter

In-Stent Restenosis

Germany
University Hospital, Saarland

Terminated

Efficacy of the SeQuent®Please in the Treatment of De-novo Stenoses Versus Taxus™Liberté™ (PEPCAD-DEBonly)

Coronary De-novo Stenoses

Germany
University of Patras

Completed

Drug Eluting Balloon Angioplasty for Dialysis Access Treatment

Dialysis | Angioplasty

Greece
Deutsches Herzzentrum Muenchen

Completed

Efficacy Study of Rapamycin- vs. Zotarolimus-Eluting Stents to Reduce Coronary Restenosis (ISAR-TEST-5)

Coronary Heart Disease

Germany
The Christie NHS Foundation Trust

Not yet recruiting

Irinotecan Drug-eluting Bead Liver Embolisation Registry (DLivERDEBIRI)

Colorectal Cancer Metastatic | Liver Metastases

United Kingdom
A.O. Ospedale Papa Giovanni XXIII
Boston Scientific Corporation; Medtronic Vascular; Case Western Reserve University

Unknown

Optical Coherence Tomography for Drug Eluting Stent Safety (ODESSA)

Coronary Artery Disease

Italy
Tongji Hospital
Geneplus-Beijing Co. Ltd.; Chinese Cooperative Group of Liver Cancer (CCGLC)

Recruiting

Combined DEB-TACE, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma (CCGLC-012)

Cholangiocarcinoma Non-resectable

China
Lepu Medical Technology (Beijing) Co., Ltd.

Recruiting

A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease

Coronary Artery Disease

China
University Hospitals, Leicester

Terminated

Transcutaneous Electrical Nerve Stimulation for Local Anaesthesia (TENS-LA)

Skin Graft | Donor Site Complication

United Kingdom
DK Medical Technology (Suzhou) Co., Ltd.
Core Medical (Beijing) Co., Ltd.

Active, not recruiting

A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary Small Vessel Disease

Coronary Small Vessel Disease

China
Deutsches Herzzentrum Muenchen

Unknown

Paclitaxel Eluting Balloon and Conventional Balloon for In-Stent Restenosis of the Superficial Femoral Artery (ISAR-PEBIS)

Peripheral Vascular Disease

Germany
Jena University Hospital
KKS Netzwerk; iVascular S.L.U.

Completed

Effectiveness of Paclitaxel-coated Luminor® Balloon Catheter Versus Uncoated Balloon Catheter in the Arteria Femoralis Superficialis (EffPac)

Peripheral Arterial Disease

Germany
Washington University School of Medicine

Terminated

The LC Bead Trial; Transarterial Chemoembolization of Hepatocellular Carcinoma (HCC)With a Drug-eluting Bead

Hepatocellular Carcinoma

United States
Xuanwu Hospital, Beijing

Recruiting

Drug-eluting Stenting Versus Medical Treatment for Extracranial Vertebral Artery Stenosis (VISTA)

Ischemic Stroke | Vertebral Artery Stenosis

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Firehawk Rapamycin Target Eluting Coronary Stent North American Trial (TARGET-IV_NA)

Coronary Artery Disease

United States, Denmark, Canada, Belgium, Netherlands
Chonnam National University Hospital

Unknown

Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome (BEAUTY-II)

Myocardial Infarction | Hemorrhage | Cerebrovascular Accident | Cardiac Death

Korea, Republic of
Yinyi(Liaoning) Biotech Co., Ltd.

Not yet recruiting

Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions

Coronary Artery Disease
University of California, San Francisco
Northwestern University

Completed

Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

United States
Medical College of Wisconsin

Not yet recruiting

Puerto Rican Obesity Intervention for Men

Obesity

United States
Ain Shams University

Completed

Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients

HepatoCellular Carcinoma
Marco Valgimigli

Completed

Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention (PRODIGY)

Coronary Artery Disease

Italy
Translational Research in Oncology
Bayer

Recruiting

Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7 (REPLACE)

Carcinoma, Hepatocellular

Korea, Republic of, United States, Taiwan, Spain, Japan, France, Georgia, Belgium, Germany, Turkey, Italy, Hong Kong, Serbia
Gangnam Severance Hospital

Completed

Optimal Duration of Clopidogrel in Second-Generation Drug-Eluting Stents (OPTIMA-C)

Ischemic Heart Disease
University of Minnesota

Withdrawn

Comparing Lipiodol/Ethanol With Drug-eluting Beads (DEB) for Hepatocellular Carcinoma

Hepatocellular Carcinoma

United States
Semmelweis University

Recruiting

The Effect of an Additional Pre-extubational Loading Dose of Caffeine-citrate (NEOKOFF22)

Premature Birth | Respiratory Failure | Apnea of Prematurity

Hungary
Beijing Anzhen Hospital

Enrolling by invitation

Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions

Coronary Artery Disease | Percutaneous Coronary Intervention | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Drug-Eluting Stents

China
Xijing Hospital

Active, not recruiting

Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery Lesions (CAGE-FREEIII)

Coronary Artery Disease | Percutaneous Coronary Intervention | De Novo Stenosis

China
IGLESIAS Juan Fernando
Clinical Trials Unit University of Bern

Not yet recruiting

STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT (STARS DAPT)

ST Elevation Myocardial Infarction

Switzerland
Amgen

Active, not recruiting

Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

Castleman Disease | Lymphangioleiomyomatosis | Digestive System Carcinoma | Malignant Neoplasm | Recurrent Breast Carcinoma | Recurrent Thyroid Gland Carcinoma | Metastatic Urothelial Carcinoma | Malignant Female Reproductive System Neoplasm | Neurofibromatosis Type 2 | Recurrent Adult Soft Tissue Sarcoma and other conditions

United States
Monica Bhatia

Completed

Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease

Sickle Cell Disease | Graft Versus Host Disease

United States
SWOG Cancer Research Network
National Cancer Institute (NCI)

Recruiting

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma

United States
National Cancer Institute (NCI)

Completed

Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma

Recurrent Childhood Acute Lymphoblastic Leukemia | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Childhood Lymphoblastic Lymphoma | Childhood T Acute Lymphoblastic Leukemia | Childhood B Acute Lymphoblastic Leukemia

United States, Canada
Fred Hutchinson Cancer Center
National Heart, Lung, and Blood Institute (NHLBI)

Suspended

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Non-Malignant Neoplasm

United States

Search clinical trials for: sirolimus-eluting balloon (SEB) MagicTouch

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations